SAGENT PHARMACEUTICALS INC - COM (SGNT)

CUSIP: 786692103

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
24,521,084
Share change
+805,127
Total reported value
$615,813,179
Price per share
$25.11
Number of holders
130
Value change
+$18,456,040
Number of buys
83
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 786692103?
CUSIP 786692103 identifies SGNT - SAGENT PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q4 2014

As of 31 Dec 2014, SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,521,084 shares. The largest 10 holders included FRANKLIN RESOURCES INC, MORGAN STANLEY, BlackRock Fund Advisors, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, State Street Corp, Ranger Investment Management, L.P., Sectoral Asset Management Inc, JPMORGAN CHASE & CO, and NWQ INVESTMENT MANAGEMENT COMPANY, LLC. This page lists 130 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.